Jeff Bruce

1.9k total citations
24 papers, 1.3k citations indexed

About

Jeff Bruce is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Jeff Bruce has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cancer Research, 15 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Jeff Bruce's work include Cancer-related molecular mechanisms research (13 papers), MicroRNA in disease regulation (11 papers) and Circular RNAs in diseases (7 papers). Jeff Bruce is often cited by papers focused on Cancer-related molecular mechanisms research (13 papers), MicroRNA in disease regulation (11 papers) and Circular RNAs in diseases (7 papers). Jeff Bruce collaborates with scholars based in Canada, United States and France. Jeff Bruce's co-authors include Fei‐Fei Liu, Kenneth W. Yip, Tara Spence, Peter Canoll, Alfred T. Ogden, Richard A. Lochhead, Wei Shi, James E. Goldman, Angela Bik‐Yu Hui and Emma Ito and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Jeff Bruce

24 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeff Bruce Canada	19	861	726	326	154	131	24	1.3k
Frauke Devens Germany	15	657 0.8×	306 0.4×	302 0.9×	204 1.3×	85 0.6×	17	1.0k
Jiří Šáňa Czechia	22	1.1k 1.3×	1.1k 1.5×	204 0.6×	165 1.1×	22 0.2×	65	1.6k
Adrian Biddle United Kingdom	19	887 1.0×	557 0.8×	985 3.0×	175 1.1×	41 0.3×	27	1.7k
Molly A. Smith United States	12	668 0.8×	204 0.3×	227 0.7×	67 0.4×	215 1.6×	22	1.2k
Z Stasková Czechia	10	641 0.7×	277 0.4×	943 2.9×	45 0.3×	35 0.3×	14	1.4k
Luke Gammon United Kingdom	17	624 0.7×	355 0.5×	574 1.8×	62 0.4×	25 0.2×	25	1.2k
Kasumi Murai United Kingdom	15	957 1.1×	507 0.7×	334 1.0×	64 0.4×	8 0.1×	19	1.5k
Agnieszka Wabik United Kingdom	7	793 0.9×	463 0.6×	469 1.4×	83 0.5×	7 0.1×	7	1.4k
Ravi Mylvaganam United States	4	1.0k 1.2×	646 0.9×	802 2.5×	44 0.3×	83 0.6×	5	1.6k
Sandra H. Bigner United States	11	781 0.9×	297 0.4×	423 1.3×	660 4.3×	9 0.1×	11	1.5k

Countries citing papers authored by Jeff Bruce

Since Specialization

Citations

This map shows the geographic impact of Jeff Bruce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Bruce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Bruce more than expected).

Fields of papers citing papers by Jeff Bruce

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Bruce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Bruce. The network helps show where Jeff Bruce may publish in the future.

Co-authorship network of co-authors of Jeff Bruce

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Bruce. A scholar is included among the top collaborators of Jeff Bruce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Bruce. Jeff Bruce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spiliopoulou, Pavlina, S.Y. Cindy Yang, Jeff Bruce, et al.. (2022). All is not lost: learning from 9p21 loss in cancer. Trends in Immunology. 43(5). 379–390. 24 indexed citations

Chow, Signy, Olena Kis, David T. Mulder, et al.. (2022). Myeloma immunoglobulin rearrangement and translocation detection through targeted capture sequencing. Life Science Alliance. 6(1). e202201543–e202201543. 6 indexed citations

Teng, Mona, Wei Shi, Jeff Bruce, et al.. (2020). MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma. BMC Cancer. 20(1). 597–597. 27 indexed citations

Quevedo, Rene, Anna Spreafico, Jeff Bruce, et al.. (2020). Centromeric cohesion failure invokes a conserved choreography of chromosomal mis-segregations in pancreatic neuroendocrine tumor. Genome Medicine. 12(1). 38–38. 12 indexed citations

Bruce, Jeff, et al.. (2018). Dysregulation of the MiR-449b target TGFBI alters the TGFβ pathway to induce cisplatin resistance in nasopharyngeal carcinoma. Oncogenesis. 7(5). 40–40. 34 indexed citations

Bruce, Jeff, et al.. (2018). Bamgineer: Introduction of simulated allele-specific copy number variants into exome and targeted sequence data sets. PLoS Computational Biology. 14(3). e1006080–e1006080. 4 indexed citations

Lheureux, Stéphanie, Jeff Bruce, Julia V. Burnier, et al.. (2017). Somatic BRCA1/2 Recovery as a Resistance Mechanism After Exceptional Response to Poly (ADP-ribose) Polymerase Inhibition. Journal of Clinical Oncology. 35(11). 1240–1249. 73 indexed citations

Spence, Tara, Jeff Bruce, Kenneth W. Yip, & Fei‐Fei Liu. (2016). MicroRNAs in nasopharyngeal carcinoma. Chinese Clinical Oncology. 5(2). 17–17. 50 indexed citations

Kwan, Jennifer, et al.. (2016). The complexity of microRNAs in human cancer. Journal of Radiation Research. 57(S1). i106–i111. 55 indexed citations

10.

Shi, Wei, Jeff Bruce, Matthew Lee, et al.. (2016). MiR-449a promotes breast cancer progression by targeting CRIP2. Oncotarget. 7(14). 18906–18918. 48 indexed citations

11.

How, Christine, Jeff Bruce, Jonathan So, et al.. (2015). Chromosomal instability as a prognostic marker in cervical cancer. BMC Cancer. 15(1). 361–361. 18 indexed citations

12.

Bruce, Jeff, Angela B. Hui, Wei Shi, et al.. (2015). Identification of a microRNA signature associated with risk of distant metastasis in nasopharyngeal carcinoma. Oncotarget. 6(6). 4537–4550. 50 indexed citations

13.

Wong, Philip, Angela Bik‐Yu Hui, Jie Su, et al.. (2015). Prognostic microRNAs modulate the RHO adhesion pathway: A potential therapeutic target in undifferentiated pleomorphic sarcomas. Oncotarget. 6(36). 39127–39139. 14 indexed citations

14.

How, Christine, Melania Pintilie, Jeff Bruce, et al.. (2015). Developing a Prognostic Micro-RNA Signature for Human Cervical Carcinoma. PLoS ONE. 10(4). e0123946–e0123946. 27 indexed citations

15.

Bruce, Jeff & Fei‐Fei Liu. (2014). MicroRNAs in nasopharyngeal carcinoma. Chinese Journal of Cancer. 33(11). 539–544. 33 indexed citations

16.

Hui, Angela Bik‐Yu, Alice Lin, Wei Xu, et al.. (2013). Potentially Prognostic miRNAs in HPV-Associated Oropharyngeal Carcinoma. Clinical Cancer Research. 19(8). 2154–2162. 88 indexed citations

17.

Principe, Simona, Angela Bik‐Yu Hui, Jeff Bruce, et al.. (2013). Tumor‐derived exosomes and microvesicles in head and neck cancer: Implications for tumor biology and biomarker discovery. PROTEOMICS. 13(10-11). 1608–1623. 95 indexed citations

18.

Hui, Angela Bik‐Yu, Jeff Bruce, Nehad M. Alajez, et al.. (2011). Significance of Dysregulated Metadherin and MicroRNA-375 in Head and Neck Cancer. Clinical Cancer Research. 17(24). 7539–7550. 78 indexed citations

19.

Bruce, Jeff, Angela Bik‐Yu Hui, Nehad M. Alajez, et al.. (2011). Abstract 3967: Identification of metadherin as a novel target of miR-375 in head and neck cancer. Cancer Research. 71(8_Supplement). 3967–3967. 1 indexed citations

20.

Lochhead, Richard A., et al.. (2006). Glial Progenitors in Adult White Matter Are Driven to Form Malignant Gliomas by Platelet-Derived Growth Factor-Expressing Retroviruses. Journal of Neuroscience. 26(25). 6781–6790. 221 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact